LIDOCAINE HYDROCHLORIDE + PHENAZONE EAR DROPS (Otigo®)

Clinical Indication

Local symptomatic treatment and relief of pain in specified diseases of the middle ear without tympanic perforation.

Comments

Not yet reviewed

Date of classification

December 2020

Grey

Not yet reviewed drugs with no traffic light recommendation so not yet approved for use in LLR.

  • New medicines, devices, appliances.
  • New indication of existing medicine.
  • New NICE TA which has not been reviewed.
  • Not been requested for review by either TAS/LPT MMC.